Clinical Trials Directory

Trials / Conditions / Pathologic Stage IV Gastric Cancer AJCC v8

Pathologic Stage IV Gastric Cancer AJCC v8

11 registered clinical trials studyying Pathologic Stage IV Gastric Cancer AJCC v8 — 4 currently recruiting.

StatusTrialSponsorPhase
RecruitingPembrolizumab and Lenvatinib for the Treatment of Advanced, Unresectable, or Metastatic Gastroesophageal Adeno
NCT05041153
M.D. Anderson Cancer CenterEARLY_Phase 1
RecruitingRamucirumab and Trifluridine/Tipiracil or Paclitaxel for the Treatment of Patients With Previously Treated Adv
NCT04660760
Academic and Community Cancer Research UnitedPhase 2
Active Not RecruitingEnhanced Outpatient Symptom Management to Reduce Acute Care Visits Due to Chemotherapy-Related Adverse Events
NCT05038254
M.D. Anderson Cancer CenterN/A
RecruitingPIPAC for the Treatment of Peritoneal Carcinomatosis in Patients With Ovarian, Uterine, Appendiceal, Colorecta
NCT04329494
City of Hope Medical CenterPhase 1
RecruitingRadiation Therapy for the Treatment of Metastatic Gastrointestinal Cancers
NCT04221893
University of California, San FranciscoN/A
Active Not RecruitingTesting the Addition of Radiotherapy to the Usual Treatment (Chemotherapy) for Patients With Esophageal and Ga
NCT04248452
ECOG-ACRIN Cancer Research GroupPhase 3
CompletedReal-Time Monitoring of Chemotherapy Side-Effects in Patients With Gastrointestinal Cancers, RT-CAMSS Study
NCT04449679
Thomas Jefferson UniversityN/A
CompletedRemote Telemonitoring of Patient-Generated Physiologic Health Data and Patient-Reported Outcomes
NCT04501913
City of Hope Medical Center—
Active Not RecruitingPaclitaxel for the Treatment of Gastric or Gastroesophageal Cancer
NCT04220827
M.D. Anderson Cancer CenterPhase 1
CompletedIRX-2, Cyclophosphamide, and Pembrolizumab in Treating Participants With Recurrent or Metastatic Gastric or Ga
NCT03918499
City of Hope Medical CenterPhase 1 / Phase 2
CompletedPembrolizumab in Treating Patients With Metastatic or Unresectable Gastroesophageal Adenocarcinoma
NCT03395847
M.D. Anderson Cancer CenterEARLY_Phase 1